Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Zytiga 250 mg Tablet
Manufacturer/Marketed By : Johnson & Johnson Pvt Ltd
$1699.91 $1325.93
Zytiga 250 mg tablets are an essential treatment option for adult men battling advanced prostate cancer, particularly in cases where the disease has metastasized and has not responded to previous...
Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.
Abiraterone Acetate 250 mg
Active Pharmaceutical Ingredient
Zytiga 250 mg Tablet
1.699,91$
1.325,93$
Zytiga 250 mg tablets are an essential treatment option for adult men battling advanced prostate cancer, particularly in cases where the disease has metastasized and has not responded to previous therapies, including chemotherapy. This medication works in conjunction with corticosteroids like prednisone or methylprednisolone to effectively inhibit the production of testosterone in the body, a hormone that can fuel the growth of prostate cancer cells. By lowering testosterone levels, Zytiga helps to slow the progression of the disease, providing patients with a valuable tool in their treatment arsenal. It is crucial for patients to discuss potential side effects and interactions with their healthcare provider, as Zytiga may cause liver-related complications and should be used with caution. Regular monitoring of liver function and other health parameters is recommended during treatment. With its targeted approach, Zytiga represents a significant advancement in the management of prostate cancer, offering hope to those affected by this challenging condition. Always consult with your healthcare professional to ensure that Zytiga is an appropriate choice for your individual treatment plan.
Active Pharmaceutical Ingredient
Uses
• Zytiga 250 mg tablet is primarily used in the treatment of prostate cancer, specifically in cases where the cancer has advanced or metastasized. This medication works by inhibiting the production of androgens, which are hormones that can fuel the growth of prostate cancer cells. By reducing androgen levels, Zytiga 250 mg tablet helps to slow down the progression of the disease. Patients often benefit from this treatment when other therapies have proven ineffective.
• In patients with metastatic castration-resistant prostate cancer, Zytiga 250 mg tablet plays a critical role in managing their condition. This stage of prostate cancer occurs when the disease continues to progress despite low testosterone levels. The active ingredient in Zytiga 250 mg tablet helps to further lower androgen production, providing a therapeutic option for these patients. Regular use can lead to improved outcomes and a better quality of life.
• Zytiga 250 mg tablet may also be prescribed in combination with other treatments for prostate cancer, enhancing overall effectiveness. When used alongside corticosteroids, it can improve the response to therapy and help manage symptoms more effectively. This combination approach allows for a comprehensive treatment plan tailored to the patient's specific needs. Clinicians often recommend Zytiga 250 mg tablet in these scenarios to maximize therapeutic benefits.
• For patients experiencing symptoms associated with advanced prostate cancer, Zytiga 250 mg tablet can help alleviate some of these challenges. While it primarily targets cancer progression, many patients report a reduction in symptoms related to the disease. This medication supports overall treatment goals by addressing both the biological and symptomatic aspects of prostate cancer. Consequently, Zytiga 250 mg tablet is an essential part of many treatment regimens for prostate cancer patients.
Benefits
Zytiga 250 mg Tablet decreases the production of testosterone in males. In this way, the cancer cells decrease or stop growing due to low testosterone levels in the body.
How Zytiga 250 mg Tablet works can slow the growth of prostate cancer cells and reduce the size of tumors.
Benefits of Zytiga 250 mg Tablet can delay the need for other treatments such as chemotherapy or radiation therapy and prolong survival in people with advanced prostate cancer.
Side Effects
Uses of Zytiga 250 mg Tablet may cause some side effects. If you experience any of these side effects, contact your doctor as soon as possible. Your doctor may be able to suggest ways to manage or reduce the severity of these side effects.
Most Common Side Effects
• Urinary tract infection
• Hypokalemia
• Hypertension
• Diarrhoea
• Peripheral oedema
Common Side Effects
• Hypertriglyceridaemia
• Sepsis
• Cardiac failure
• Angina pectoris
• Arrhythmia
• Atrial fibrillation
• Tachycardia
• Dyspepsia (indigestion)
• Rash
• Alanine aminotransferase increased
• Fatigue
• Joint pain
• Hot flashes
• Nausea
How To Use
Zytiga 250 mg Tablet taken by mouth once a day on an empty stomach. Do not eat food 2 hours before and 1 hour after taking Zytiga 250 mg. Swallow the tablet whole with a full glass of water. Do not crush, chew, or open the tablet. If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and take the next dose at the regular time. Do not take two doses simultaneously to make up for a missed dose.
Safety Advice
• Alcohol: It is generally not recommended to drink alcohol while taking Zytiga 250 mg Tablet. It may increase the risk of liver damage. it is best to avoid alcohol or limit your alcohol consumption while taking any medication.
• Kidney: Zytiga 250 mg Tablet is safe to use in patients with kidney disease. No dose adjustment of Zytiga 250 mg is recommended. If you experience any side effects please consult your doctor.
• Breastfeeding: It is not recommended to breastfeed while taking Side effects of Zytiga 250 mg Tablet. Zytiga 250 mg may pass into breast milk and harm the infant. If you are breastfeeding and taking Uses of Zytiga 250 mg Tablet, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: It is important to use caution when taking Zytiga 250 mg Tablet if you have liver disease, as the dose of the medication may need to be adjusted. It is recommended to consult with your doctor about the appropriate use of this medication in your specific situation.
• Pregnancy: Use of Zytiga 250 mg Tablet may be unsafe during pregnancy, as animal studies indicate that it may harm the developing fetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Zytiga 250 mg during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Zytiga 250 mg Tablet is unlikely to affect your ability to drive or operate machinery. If you experience any side effects while taking Side effects of Zytiga 250 mg Tablet, such as dizziness or drowsiness, it is important to avoid driving or operating heavy machinery until the side effects have resolved.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.